查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲幹細胞治療市場預測至 2028 年 - 區域分析 - 按類型、治療、應用和最終用戶
市場調查報告書
商品編碼
1402732

南美洲和中美洲幹細胞治療市場預測至 2028 年 - 區域分析 - 按類型、治療、應用和最終用戶

South & Central America Stem Cell Therapy Market Forecast to 2028 - Regional Analysis - by Type, Treatment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 120 Pages | 訂單完成後即時交付

價格

南美洲和中美洲幹細胞療法預計將從2022年的7,516萬美元成長到2028年的1.393億美元。預計2022年至2028年CAGR為10.8%。

誘導多能幹細胞在再生醫學的使用推動了南美洲和中美洲幹細胞治療市場

根據 Frontiers Media SA 2023 報告，誘導多能幹細胞 (iPSC) 領域的進展為治療學研究開闢了新的途徑。 iPSC 主要用於疾病建模、再生醫學和藥物發現/藥物細胞毒性研究等研究和臨床研究。例如，iPSC 可用於將分化的體細胞轉化為多能幹細胞，以產生成體組織的不同細胞類型。因此，iPSC 在再生醫學中顯示出有希望的結果，特別是在替換患病或受傷的細胞方面。 iPSC 廣泛用於再生組織特異性細胞，用於移植到患者體內以治療損傷和退化性疾病。涉及小分子篩選的藥物發現和用於安全評估的毒性測試等研究已成功揭露基於 iPSC 的正面結果。上述因素預計將在未來幾年為南美洲和中美洲幹細胞治療市場的公司提供利潤豐厚的成長機會。

南美洲和中美洲幹細胞治療概述

巴西政府和醫療機構正在實施建設性策略，以提高各國對幹細胞療法的認知和接觸。例如，為了提供國際曝光，當局正專注於在國內進行臨床試驗。例如，根據 ClinicalTrials.gov 的數據，2016 年，該國正在進行約 27 項幹細胞研究，估計佔全球所有幹細胞研究的 1.7%。此外，國家在進入幹細胞領域之初就撥款約500萬美元用於幹細胞研究。該國意識的提高正在推動幹細胞市場創新和發現的成長。例如，2017 年，巴西新創公司 R-Crio 發現了一種從一顆乳牙產生約 700 萬個幹細胞的方法。這些因素可能會在預測期內推動巴西幹細胞治療市場的成長。

南美洲和中美洲幹細胞治療收入及 2028 年預測（百萬美元）

南美洲和中美洲幹細胞治療細分

南美洲和中美洲幹細胞療法分為類型、治療、應用、最終用戶和國家。

根據類型，南美洲和中美洲幹細胞療法分為成體幹細胞療法、胚胎幹細胞療法、誘導性多能幹細胞療法和其他幹細胞療法。 2022年，成體幹細胞治療領域在南美洲和中美洲幹細胞治療中佔據最大佔有率。成體幹細胞治療細分為造血幹細胞治療、臍帶幹細胞治療、神經元幹細胞治療及間質幹細胞治療。

根據治療方式，南美洲和中美洲幹細胞療法分為同種異體和自體幹細胞療法。 2022年，同種異體部分在南美洲和中美洲幹細胞治療中佔據更大佔有率。

根據應用，南美洲和中美洲幹細胞療法分為肌肉骨骼、皮膚病學、心臟病學、藥物發現和開發以及其他應用。 2022年，肌肉骨骼領域在南美洲和中美洲幹細胞治療中佔據最大佔有率。

根據最終用戶，南美洲和中美洲幹細胞療法分為醫院和專科診所以及學術和研究機構。 2022年，學術和研究機構部門在南美洲和中美洲幹細胞治療中佔據了更大的佔有率。

根據國家/地區，南美洲和中美洲幹細胞治療分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022年，巴西市場在南美洲和中美洲幹細胞治療領域佔據最大佔有率。

Lonza Group AG、Pluri Inc、Smith & Nephew Plc 和 TiGenix NV（武田製藥有限公司）是南美洲和中美洲幹細胞治療領域的一些領先公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 南美洲和中美洲幹細胞治療市場 - 按類型
    • 南美洲和中美洲幹細胞治療市場 - 按治療分類
    • 南美洲和中美洲幹細胞治療市場 -按應用
    • 南美洲和中美洲幹細胞治療市場 - 按最終用戶
    • 南美洲和中美洲幹細胞治療市場 - 按國家/地區

第 2 章：南美洲和中美洲幹細胞治療市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲幹細胞治療市場 - 市場模式

  • 概述
  • 南美洲和中美洲 PEST 分析
  • 專家意見

第 5 章：南美洲和中美洲幹細胞治療市場 - 主要市場動態

  • 市場促進因素
    • 增加與幹細胞治療相關的研究活動以實現有效的疾病管理
    • 癌症盛行率不斷上升
  • 市場限制
    • 核准的治療費用高昂
  • 市場機會
    • 誘導多能幹細胞在再生醫學的應用
  • 未來的趨勢
    • 研究活動和產品創新
  • 影響分析

第 6 章：幹細胞治療市場 - 南美洲和中美洲分析

  • 南美洲和中美洲幹細胞治療市場收入預測與分析

第 7 章：南美洲和中美洲幹細胞治療市場 - 2028 年收入和預測 - 按類型

  • 概述
  • 南美洲和中美洲幹細胞治療市場收入佔有率，按類型 2021 年和 2028 年 (%)
  • 成體幹細胞治療
  • 胚胎幹細胞治療
  • 誘導性多能幹細胞療法
  • 其他幹細胞療法

第 8 章：南美洲和中美洲幹細胞治療市場分析和 2028 年預測 - 按治療方法

  • 概述
  • 南美洲和中美洲幹細胞治療市場，依治療方法分類 2021 年和 2028 年 (%)
  • 同種異體
  • 自體

第 9 章：南美洲和中美洲幹細胞治療市場分析及 2028 年預測 -按應用

  • 概述
  • 南美洲和中美洲幹細胞治療市場，按應用分類 2021 年和 2028 年（%）
  • 肌肉骨骼
  • 皮膚科
  • 心臟病學
  • 藥物發現與開發
  • 其他應用

第 10 章：南美洲和中美洲幹細胞治療市場 - 收入和 2028 年預測 - 按最終用戶

  • 概述
  • 2021 年和 2028 年南美洲和中美洲幹細胞治療市場收入佔有率（按最終用戶分類）（%）
  • 學術及研究機構
  • 醫院和專科診所

第 11 章：南美洲和中美洲幹細胞治療市場 - 2028 年收入和預測 - 國家分析

    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地區

第 12 章：南美洲和中美洲幹細胞治療市場-產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 13 章：公司簡介

  • TiGenix NV (Takeda Pharmaceutical Company Limited)
  • NuVasive Inc
  • Lonza Group AG
  • Smith & Nephew Plc

第 14 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00029077

The South & Central America stem cell therapy is expected to grow from US$ 75.16 million in 2022 to US$ 139.30 million by 2028. It is estimated to grow at a CAGR of 10.8% from 2022 to 2028.

Use of Induced Pluripotent Stem Cells in Regenerative Medicines Drives South & Central America Stem Cell Therapy Market

Per the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened a new gateway for research in therapeutics. iPSCs are mainly intended for research and clinical studies such as disease modeling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Thus, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. iPSCs are widely used to regenerate tissue-specific cells for transplantation in patients for treating injuries and degenerative diseases. Studies such as drug discovery involving screening of small molecules and toxicity testing for safety assessment have been successfully disclosed positive iPSCs-based results. The aforementioned factors are expected to offer lucrative growth opportunities to companies in the South & Central America stem cell therapy market in the coming years.

South & Central America Stem Cell Therapy Overview

The government and healthcare authorities in Brazil are implementing constructive strategies to increase the awareness and exposure of stem cell therapies in the countries. For example, providing international exposure, the authorities are focusing on conducting clinical trials in the country. For instance, according to clinicaltrials.gov, in 2016, around 27 stem cell studies were being conducted in the country, which accounted for an estimated 1.7% of all the stem cell studies across the globe. Also, the country allotted around US$ 5.0 Mn for stem cell research at the starting beginning of the entry in the stem cell domain. Increasing awareness in the country is fueling the growth of innovations and discoveries in the stem cell market. For instance, in 2017, R-Crio, a Brazil-based startup, discovered a way to produce around 7 million stem cells from a single baby tooth. These factors are likely to drive the growth of the Brazil stem cell therapy market during the forecast period.

South & Central America Stem Cell Therapy Revenue and Forecast to 2028 (US$ Million)

South & Central America Stem Cell Therapy Segmentation

The South & Central America stem cell therapy is segmented into type, treatment, application, end user, and country.

Based on type, the South & Central America stem cell therapy is segmented into adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. In 2022, the adult stem cell therapy segment registered the largest share in the South & Central America stem cell therapy. The adult stem cell therapy segments is further segmented into hematopoietic stem cell therapy, umbilical cord stem cell therapy, neuronal stem cell therapy, and mesenchymal stem cell.

Based on treatment, the South & Central America stem cell therapy is bifurcated into allogeneic and autologous. In 2022, the allogeneic segment registered a larger share in the South & Central America stem cell therapy.

Based on application, the South & Central America stem cell therapy is segmented into musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications. In 2022, the musculoskeletal segment registered the largest share in the South & Central America stem cell therapy.

Based on end user, the South & Central America stem cell therapy is bifurcated into hospitals & specialty clinics and academic & research institutes. In 2022, the academic & research institutes segment registered a larger share in the South & Central America stem cell therapy.

Based on country, the South & Central America stem cell therapy is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil segment registered the largest share in the South & Central America stem cell therapy.

Lonza Group AG, Pluri Inc, Smith & Nephew Plc, and TiGenix NV (Takeda Pharmaceutical Company Limited) are some of the leading companies operating in the South & Central America stem cell therapy.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America stem cell therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America stem cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the stem cell therapy market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Stem Cell Therapy Market - By Type
    • 1.3.2 South & Central America Stem Cell Therapy Market - By Treatment
    • 1.3.3 South & Central America Stem Cell Therapy Market - By Application
    • 1.3.4 South & Central America Stem Cell Therapy Market - By End User
    • 1.3.5 South & Central America Stem Cell Therapy Market - By Country

2. South & Central America Stem Cell Therapy Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Stem Cell Therapy Market- Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. South & Central America Stem Cell Therapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
    • 5.1.2 Growing Prevalence of Cancer
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Approved Treatments
  • 5.3 Market Opportunities
    • 5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
  • 5.4 Future Trends
    • 5.4.1 Research Activities and Product Innovations
  • 5.5 Impact Analysis

6. Stem Cell Therapy Market - South & Central America Analysis

  • 6.1 South & Central America Stem Cell Therapy Market Revenue Forecast and Analysis

7. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 South & Central America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
  • 7.3 Adult Stem Cell Therapy
    • 7.3.1 Overview
    • 7.3.2 Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.3 Hematopoietic Stem Cell Therapy
      • 7.3.3.1 Overview
      • 7.3.3.2 Hematopoietic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.4 Umbilical Cord Stem Cell Therapy
      • 7.3.4.1 Overview
      • 7.3.4.2 Umbilical Cord Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.5 Neuronal Stem Cell Therapy
      • 7.3.5.1 Overview
      • 7.3.5.2 Neuronal Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.6 Mesenchymal Stem Cell
      • 7.3.6.1 Overview
      • 7.3.6.2 Mesenchymal Stem Cell: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Embryonic Stem Cell Therapy
    • 7.4.1 Overview
    • 7.4.2 Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Induced Pluripotent Stem Cell Therapy
    • 7.5.1 Overview
    • 7.5.2 Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Other Stem Cell Therapy
    • 7.6.1 Overview
    • 7.6.2 Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Treatment

  • 8.1 Overview
  • 8.2 South & Central America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
  • 8.3 Allogeneic
    • 8.3.1 Overview
    • 8.3.2 Allogeneic: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Autologous
    • 8.4.1 Overview
    • 8.4.2 Autologous: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Application

  • 9.1 Overview
  • 9.2 South & Central America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
  • 9.3 Musculoskeletal
    • 9.3.1 Overview
    • 9.3.2 Musculoskeletal: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Dermatology
    • 9.4.1 Overview
    • 9.4.2 Dermatology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiology
    • 9.5.1 Overview
    • 9.5.2 Cardiology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Drug Discovery and Development
    • 9.6.1 Overview
    • 9.6.2 Drug Discovery and Development: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Other Applications
    • 9.7.1 Overview
    • 9.7.2 Other Applications: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - by End User

  • 10.1 Overview
  • 10.2 South & Central America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
  • 10.3 Academic & Research Institutes
    • 10.3.1 Overview
    • 10.3.2 Academic & Research Institutes: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Hospitals & Specialty Clinics
    • 10.4.1 Overview
    • 10.4.2 Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - Country Analysis

  • 11.1 Overview
    • 11.1.1 South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028(%)
      • 11.1.1.1 Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.1 Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.2 Brazil: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
        • 11.1.1.1.2.1 Brazil: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
        • 11.1.1.1.3 Brazil: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
        • 11.1.1.1.4 Brazil: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
        • 11.1.1.1.5 Brazil: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
      • 11.1.1.2 Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.1 Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.2 Argentina: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
        • 11.1.1.2.2.1 Argentina: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
        • 11.1.1.2.3 Argentina: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
        • 11.1.1.2.4 Argentina: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
        • 11.1.1.2.5 Argentina: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
      • 11.1.1.3 Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.1 Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.2 Rest of South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
        • 11.1.1.3.2.1 Rest of South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
        • 11.1.1.3.3 Rest of South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
        • 11.1.1.3.4 Rest of South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
        • 11.1.1.3.5 Rest of South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

12. South & Central America Stem Cell Therapy Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Developments
    • 12.2.1 Overview
  • 12.3 Inorganic Developments
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 TiGenix NV (Takeda Pharmaceutical Company Limited)
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 NuVasive Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lonza Group AG
    • 13.3.1 Business Description
    • 13.3.2 Products and Services
    • 13.3.3 Financial Overview
    • 13.3.4 SWOT Analysis
    • 13.3.5 Key Developments
  • 13.4 Smith & Nephew Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Brazil Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 2. Brazil Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
  • Table 3. Brazil Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
  • Table 4. Brazil Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Brazil Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Argentina Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 7. Argentina Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Argentina Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Argentina Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Argentina Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Rest of South and Central America Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Rest of South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Rest of South and Central America Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Rest of South and Central America Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Rest of South and Central America Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Organic Developments in the South & Central America stem cell therapy market
  • Table 17. Inorganic Developments in the South & Central America stem cell therapy market
  • Table 18. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Stem Cell Therapy Market Segmentation
  • Figure 2. South & Central America Stem Cell Therapy Segmentation, By Country
  • Figure 3. South & Central America Stem Cell Therapy Market Overview
  • Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in South & Central America Stem Cell Therapy Market
  • Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. South & Central America (SCAM) PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. South & Central America Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
  • Figure 9. South & Central America Stem Cell Therapy Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. South & Central America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
  • Figure 11. Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Hematopoietic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Umbilical Cord Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Neuronal Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Mesenchymal Stem Cell: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. South & Central America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
  • Figure 20. Allogeneic: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Autologous: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. South & Central America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
  • Figure 23. Musculoskeletal: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Dermatology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Cardiology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Drug Discovery and Development: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Other Applications: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 29. Academic & Research Institutes: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. South and Central America Stem Cell Therapy Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 32. South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
  • Figure 33. Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 34. Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 35. Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)